Positive impactCompany
Stocks To Buy: Motilal Oswal expects this insurance stock to rise 31% after the IRDAI draft paper
CNBC-TV18 1 hr ago·25 Sept 2026, 3:19 am
Motilal Oswal, one of ten analysts covering Niva Bupa Health Insurance, has maintained its "buy" rating after the Insurance Regulatory and Development Authority of India (IRDAI) released a draft paper that could reshape the health‑insurance landscape. The draft suggests possible changes to pricing flexibility and product offerings, which analysts believe could benefit insurers that are well‑positioned.
Based on the draft, Motilal Oswal estimates a roughly 31% upside for Niva Bupa, reflecting expectations that the regulatory shift will improve margins and market share. For investors, such a potential lift could make the stock outperform its peers and influence the broader health‑insurance segment.
Going forward, market participants should watch for the final IRDAI guidelines, any company announcements on product strategy, and the stock’s price reaction in the next few weeks. Earnings results and sector sentiment will also be key signals to gauge whether the anticipated upside materialises.
Key takeaways
- Category: Company.
- AI reads the tone as positive (potentially bullish) for the stock.
Why it matters
A routine update. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.
